Vericel Corp.
(NASDAQ : ASTM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories -0.34%90.420.8%$441.13m
MDTMedtronic Plc -1.41%119.260.6%$426.76m
ISRGIntuitive Surgical, Inc. -4.20%589.202.4%$407.22m
DHRDanaher Corp. -0.17%162.200.7%$346.54m
TMOThermo Fisher Scientific, Inc. -0.49%333.751.0%$302.96m
BSXBoston Scientific Corp. -0.85%43.201.1%$302.84m
BDXBecton, Dickinson & Co. -0.19%278.211.1%$291.77m
SYKStryker Corp. -0.93%214.211.3%$276.32m
EWEdwards Lifesciences Corp. -0.36%230.441.2%$255.61m
BAXBaxter International, Inc. -0.36%90.771.8%$234.47m
ALGNAlign Technology, Inc. -0.30%269.986.4%$202.39m
ABMDABIOMED, Inc. -0.80%182.983.3%$192.71m
DXCMDexCom, Inc. -0.71%233.948.3%$170.58m
QGENQIAGEN NV 0.46%34.981.1%$130.34m
IDXXIDEXX Laboratories, Inc. -1.79%280.773.7%$127.16m

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies to repair and regenerate damaged tissues and organs to normal structure and function. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns comprising a total body surface area of greater than or equal to 30%. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.